EGFR and central nervous system cancer: Subsequent studies in glioma revealed both the pro-tumorigenic potential of Lyn, featuring its mediation of augmented stress resistance of gliomas [39], invasive potential [40], EGFR downstream mediator to promote cellular migration [41], as well as a tumor-suppressive role [42].